Back to Search
Start Over
[Renal cell carcinoma].
- Source :
-
Der Urologe. Ausg. A [Urologe A] 2011 Sep; Vol. 50 Suppl 1, pp. 219-22. - Publication Year :
- 2011
-
Abstract
- Approximately 85% of all malignant tumors of the kidney are renal cell carcinomas (RCC). Sonography is the leading examination for early detection of kidney tumors. The treatment of RCC has been enriched in recent years by new therapeutic options for localized and metastatic cancer. The classification of RCC is based on TNM and UICC criteria. The so-called Motzer criteria are being increasingly employed to assess prognosis and monitor therapy and as the basis for reaching decisions on choosing the type of systemic treatment.
- Subjects :
- Algorithms
Antineoplastic Agents adverse effects
Antineoplastic Agents therapeutic use
Biomarkers, Tumor blood
Carcinoma, Renal Cell diagnosis
Carcinoma, Renal Cell mortality
Carcinoma, Renal Cell pathology
Combined Modality Therapy
Disease-Free Survival
Drug Delivery Systems
Early Diagnosis
Humans
Kidney Neoplasms diagnosis
Kidney Neoplasms mortality
Kidney Neoplasms pathology
Laparoscopy methods
Lymphatic Metastasis pathology
Neoplasm Staging
Nephrectomy methods
Organ Sparing Treatments methods
Prognosis
Ultrasonography
Carcinoma, Renal Cell therapy
Kidney Neoplasms therapy
Subjects
Details
- Language :
- German
- ISSN :
- 1433-0563
- Volume :
- 50 Suppl 1
- Database :
- MEDLINE
- Journal :
- Der Urologe. Ausg. A
- Publication Type :
- Academic Journal
- Accession number :
- 21837488
- Full Text :
- https://doi.org/10.1007/s00120-011-2677-5